Mechanisms initiating lung injury in the preterm

Early Human Development

Volumn 53, Issue 1, 1998, Pages 81-94

  Jobe, Alan H ^a   Ikegami, Machiko ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Alveoli; Bronchopulmonary dysplasia; Cytokines; Respiratory distress syndrome; Surfactant

Indexed keywords

CYTOKINE; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; FETUS; HUMAN; INFANT; LUNG DYSPLASIA; LUNG INJURY; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; RESUSCITATION;

BRONCHOPULMONARY DYSPLASIA; CARBON DIOXIDE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INFLAMMATION; LUNG VOLUME MEASUREMENTS; RESPIRATION, ARTIFICIAL;

EID: 0031757169     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(98)00045-0     Document Type: Article

References (66)

1. O'Brodovich HM, Mellins RB. Bronchopulmonary dysplasia. Am Rev Respir Dis 1985;132:694-709.
2. Bancalari E. Neonatal chronic lung disease. In: Fanaroff AA, Martin RJ, editors. Neonatal-perinatal medicine. St. Louis: Mosby, 1997:1074-89.
3. Fanaroff AA, Wright LL, Stevenson DK, Shankaran S, Donovan EF, Ehrenkranz RA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. Am J Obstet Gynecol 1995;173:1423-31.
4. Toce SS, Farrell PM, Leavitt LA, Samules DP, Edwards DK. Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child 1984;138:581-5.
5. Erickson AM, de la Monte SM, Moore GW, Hutchins GM. The progression of morphologic changes in bronchopulmonary dysplasia. Am J Pathol 1987;127:474-87.
6. Chambers HM, van Velzen D. Ventilator-related pathology in the extremely immature lung. Pathology 1989;21:79-83.
7. Coalson JJ, Winter VT, Gerstmann DR, Idell S, King RJ, deLemos RA. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am Rev Respir Dis 1992;145:872-81.
8. Albertine K, Jones G, Kullama L, Carlton D, Bland R. Effects of vibratory ventilation on the histopathology of chronic lung injury in preterm lambs. Am J Respir Crit Care Med 1997;155:A238.
9. Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors with bronchopul-monary dysplasia. Am J Respir Crit Care Med 1995;152:640-6.
10. Sinkin RA, Cox C, Phelps DL. Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics 1990;86:728-36.
11. Palta M, Sadek M, Barnet JH, Evans M, Weinstein MR, McGuiness G, et al. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. J Pediatr 1998;132:57-63.
12. Ebgerts J, Brand R, Walti H, Bevilacqua G, Breart G, Gardini F. Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant curosurf. Pediatrics 1997;100:e4.
13. Jobe AH. Influence of surfactant replacement on development of bronchopulmonary dysplasia. In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy. Marcel Dekker, in press.
14. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26-30.
15. The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Pediatrics 1993;91:540-5.
16. van Marter LJ, Pagano M, Allred EN, Levitorn A, Kuban KC. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr 1992;120:938-46.
17. Kraybill EN, Runyan DK, Bose CL, Khan JH. Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr 1989;115:115-20.
18. Garland JS, Buck RK, Allred EN, Leviton A. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Arch Pediatr Adolesc Med 1995;149:617-22.
19. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-10.
20. Romero R, Mazor K, Wu Y, Sirtori M, Oyarzum E, Mitchell MD, Hobbins JC. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988;12:262-79.
21. Watts DH, Krohn KA, Hillier SL, Eschenbach DA. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992;79:351-7.
22. Bry K, Lappalainen U, Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997;99:2992-9.
23. Emerson GA, Bry K, Hallman M, Jobe AH, Wada N, Ervin MG, Ikegami M. Intra-amniotic interleukin-1α treatment alters postnatal adaptation in premature lambs. Biol Neonate 1997;72:370-9.
24. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-5.
25. Hitti J, Krohn MA, Patton DL, Tarczy-Hornoch P, Hillier SL, Cassen EM, Eschenbach DA. Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants. Am J Obstet Gynecol 1997;177:50-60.
26. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-30.
27. Matsuda T, Nakajima T, Hattori S, Hanatani K, Fukazawa Y, Kobayashi K, Fujimoto S. Necrotizing funisitis: clinical significance and association with chronic lung disease in premature infants. Am J Obstet Gynecol 1997;177:1402-7.
28. Fujimura M, Kitajima H, Nakayama M. Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema. Pediatrics 1993;92:564-9.
29. Wang EE, Ohlsson A, Kellner J. Association of ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a meta-analysis. J Pediatr 1995;127:640-4.
30. Crowley P. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials 1972-1994. Am J Obstet Gynecol 1995;173:322-35.
31. French N, Hagan R, Evans S, Godfrey M, Benninger H, Mullan A., et al. Repeated antenatal corticosteroids: growth and early childhood outcome. Proc Perinatol Soc Aust New Zealand 1997:A12.
32. Dreyfuss D, Saumon G. Ventilator-induced lung injury. Am J Respir Crit Care Med 1998;157:294-323.
33. Hernandez LA, Peevy KJ, Moise AA, Parker JC. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits. J Appl Physiol 1989;66:2364-8.
34. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung mode. J Clin Invest 1997;99:944-52.
35. Berg JT, Fu Z, Breen EC, Tran H, Mathieu-Costello O, West JB. High lung inflation increases mRNA levels of ECM components and growth factors in lung parenchyma. J Appl Physiol 1997;83:120-8.
36. Muscedere JG, Mullen JBM, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med 1994;149:1327-34.
37. Froese AB, McCullouch PR, Sugiura M, Vaclavik S, Possmayer F, Moller F. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 1993;148:569-77.
38. McCulloch PR, Forkert PG, Froese AB. Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits. Am Rev Respir Dis 1988;137:1185-92.
39. Gribetz I, Frank NR, Avery ME. Static volume-pressure relations of excised lungs of infants with hyaline membrane disease, newborn and stillborn infants. J Clin Invest 1959;38:2168-75.
40. Jackson JC, Standaert TA, Truog WE, Murphy JH, Palmer S, Chi EY, et al. Changes in lung volume and deflation stability in hyaline membrane disease. J Appl Physiol 1985;59:1783-9.
41. Vilstrup CT, Björklund LJ, Werner O, Larsson A. Lung volumes and pressure-volume relations of the respiratory system in small ventilated neonates with severe respiratory distress syndrome. Pediatr Res 1996;39:127-33.
42. Bjorklund LJ, Vilstrup CT, Larsson A, Svenningsen NW, Werner O. Changes in lung volume and static expiratory pressure-volume diagram after surfactant rescue treatment of neonates with established respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:918-23.
43. Langston C, Kida D, Reed M, Thurlbeck W. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984;129:607-13.
44. Ikegami M, Polk DH, Jobe AH, Newnham J, Sly P, Kohan R, Kelly R. Postnatal lung function in lambs after fetal hormone treatment: effects of gestational age. Am J Respir Crit Care Med 1995;152:1256-61.
45. Ikegami M, Polk D, Tabor B, Lewis J, Yamada T, Jobe A. Corticosteroid and thyrotropin-releasing hormone effects on preterm sheep lung function. J Appl Physiol 1991;70:2268-78.
46. Hislop AA, Wigglesworth JS, Desai R. Alveolar development in the human fetus and infant. Early Hum Dev 1986;13:1-11.
47. Hislop AA, Wigglesworth JS, Desai R, Aber V. The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev 1987;15:147-64.
48. Vyas H, Field D, Milner AD, Hopkin IE. Determinants of the first inspiratory volume and functional residual capacity at birth. Pediatr Pulmonol 1986;2:189-93.
49. Vyas H, Milner AD, Hopkin IE, Boon AW. Physiologic responses to prolonged and slow-rise inflation in the resuscitation of the asphyxiated newborn infant. J Pediatr 1981;99:635-9.
50. Faridy EE. Air opening pressure in fetal lungs. Respir Physiol 1987;68:293-300.
51. Kobayashi T, Shido A, Nitta K, Inui S, Ganzuka M, Robertson B. The critical concentration of surfactant in fetal lung liquid at birth. Respir Physiol 1990;80:181-92.
52. Bjorklund LL, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, Vilstrup CT. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997;42:348-55.
53. Wada K, Jobe AH, Ikegami M. Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J Appl Physiol 1997;83(4):1054-61.
54. Carlton DP, Albertine KH, Cho SC, Lont M, Bland RD. Role of neutrophils in lung vascular injury and edema after premature birth in lambs. J Appl Physiol 1997;83:1307-17.
55. Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 1995;73:F1-3.
56. Ogden BE, Murphy S, Saunders GC, Johnson JD. Lung lavage of newborns with respiratory distress syndrome. Chest 1983;83S:31S-3S.
57. Watts CL, Fanaroff AA, Bruce MC. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr 1992;120:614-20.
58. Speer CP, Ruess D, Harms K, Herting E, Gaefeller O. Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome. Pediatrics 1993;91:794-9.
59. Alnabbas MH, Karathanasis P, Kriss VM, Pauly TH, Bruce MC. Elevated laminin concentrations in lung secretions of preterm infants supported by mechanical ventilation are correlated with radiographic abnormalities. J Pediatr 1997;131:555-60.
60. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible development basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39(6):966-75.
61. Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994;150:870-4.
62. Mariana G, Cifuentes J, Carlo WA. Randomized trial of permissive hypercapnia in preterm infants: a pilot study. Pediatr Res 1997;41:163A.
63. Gerstmann DR, Minton SD, Stoddard RA, Meredith KS, Monaco F, Bertrand JM, et al. The Provo Multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome. Pediatrics 1996;98:1044-57.
64. Jackson JC, Truog WE, Standaert TA, Murphy JH, Jurel SE, Chi EY, et al. Reduction in lung injury after combined surfactant and high-frequency ventilation. Am J Respir Crit Care Med 1994;150:534-9.
65. Wiswell TE, Graziani LJ, Kornhauser MS, Cullen J, Merton DA, McKee L, Spitzer AR. High-frequency jet ventilation in the early management of respiratory distress syndrome is associated with a greater risk for adverse outcomes. Pediatrics 1996;98:1035-43.
66. Massaro GD, Massaro D. Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation. Annu Rev Physiol 1996;58:73-92.